Checkpoint Capital as of June 30, 2024
Portfolio Holdings for Checkpoint Capital
Checkpoint Capital holds 16 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Rhythm Pharmaceuticals (RYTM) | 22.8 | $38M | 922k | 41.06 | |
| Argenx Se Sponsored Adr (ARGX) | 21.3 | $35M | 82k | 430.04 | |
| Axsome Therapeutics (AXSM) | 14.1 | $23M | 291k | 80.50 | |
| Avadel Pharmaceuticals Com Shs (AVDL) | 9.6 | $16M | 1.1M | 14.06 | |
| Protagonist Therapeutics (PTGX) | 7.4 | $12M | 355k | 34.65 | |
| Cytokinetics Com New (CYTK) | 6.2 | $10M | 190k | 54.18 | |
| Phathom Pharmaceuticals (PHAT) | 5.4 | $9.0M | 875k | 10.30 | |
| Corcept Therapeutics Incorporated (CORT) | 4.8 | $8.0M | 245k | 32.49 | |
| Atyr Pharma Com New (ATYR) | 1.8 | $3.0M | 1.9M | 1.56 | |
| Pliant Therapeutics (PLRX) | 1.5 | $2.5M | 232k | 10.75 | |
| Kymera Therapeutics (KYMR) | 1.5 | $2.4M | 82k | 29.85 | |
| Cidara Therapeutics Com New (CDTX) | 1.0 | $1.7M | 145k | 11.94 | |
| Trevi Therapeutics (TRVI) | 0.9 | $1.5M | 500k | 2.98 | |
| Applied Therapeutics (APLT) | 0.6 | $1.1M | 228k | 4.67 | |
| Soleno Therapeutics (SLNO) | 0.5 | $804k | 20k | 40.80 | |
| Allakos (ALLK) | 0.4 | $650k | 650k | 1.00 |
